Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy. (Q36417330)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy. |
scientific article |
Statements
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy (English)
Patrick Hwu
Chantale Bernatchez
Elizabeth A Mittendorf
Luis M Vence
Karen Clise-Dwyer
Jeffrey J Molldrem
Rebecca S Patenia
Anna Sergeeva
Pariya Sukhumalchandra
Na Qiao
Mao Zhang
Lisa S St John
Kathryn Ruisaard
Christine E Haugen
Zein Al-Atrache
Haroon Jakher
Anne V Philips
Xiaoling Ding
Jie Qing Chen
Yun Wu
Laszlo G Radvanyi
Qing Ma
26 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference